IP Library Granted Patent US 7,480,532
Granted Patent B2
US 7,480,532 · App. 10/970,829 · Granted Jan 20, 2009

Baroreflex activation for pain control, sedation and sleep

Assignee: CVRX, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,480,532
App. No.
10/970,829
Granted
Jan 20, 2009
Kind
B2
Abstract

Systems and methods provide baroreflex activation to treat or reduce pain and/or to cause or enhance sedation or sleep. Methods involve activating the baroreflex system to provide pain reduction, sedation, improved sleep or some combination thereof. Systems include at least one baroreflex activation device, at least one sensor for sensing physiological activity of the patient, and a processor coupled with the baroreflex activation device(s) and the sensor(s) for processing sensed data received from the sensor and for activating the baroreflex activation device. In some embodiments, the system is fully implantable within a patient, such as in an intravascular, extravascular or intramural location.

Claims (14)

1. A method for effecting a change in a baroreflex system of a patient to treat or reduce chronic pain the method comprising:

identifying a patient desiring a treatment of or reduction in chronic pain;

advancing at least one baroreceptor activation device through the venous vasculature of a patient to a location;

advancing the device through a wall of the venous vasculature at the location;

implanting the device on an extravascular wall of an artery; and

activating the baroreflex system of the patient with said at least one baroreflex activation device in order to reduce the chronic pain.

2. A method as in claim 1 , where activating comprises at least one of electrical activation, mechanical activation, thermal activation and chemical activation.

3. A method as in claim 1 , wherein activating comprises at least one of continuous activation, pulsed activation and periodic activation.

4. A method as in claim 1 , wherein activating the baroreflex system also causes sedation of the patient.

5. A method as in claim 1 , further comprising:

sensing a patient condition indicative of pain with one or more sensor devices; and

initiating or modifying baroreflex activation in response to the sensed patient condition.

6. A method as in claim 5 , wherein sensing the patient condition comprises sensing at least one of the physiological and neurological activity.

7. A method as in claim 1 , wherein activating is controlled by the patient.

Assignments (2)
SECURITY INTEREST Recorded Oct 31, 2022
From: CVRX, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 061824/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2005
From: KIEVAL, ROBERT S.; ROSSING, MARTIN
To: CVRX, INC.
Reel/Frame 015877/0642 →
Continuity (2)
Provisional Application 6051364200 · Oct 22, 2003
Related Publication 20050154418A1 · Jul 14, 2005